×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| NATCO PHARMA LTD. | 12523.0 | 4641.0 | 11927.0 | 25.91 | 15,106 | 8.89 |
| Rainbow Children's Medicare Li | 3540.33 | 517.2 | 3347.48 | 5.09 | 15046 | 58.4 |
| GRANULES INDIA LTD. | 8233.6 | 694.85 | 8102.08 | 2.86 | 12671 | 26.5 |
Natco Pharma Ltd., with Security Code 524816, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 781.2 | 1,048.3 | 930.5 | 625.3 | 964.8 | 1,236.9 | 1,292.6 | 407.6 | 1,157.4 | 1,192.7 |
| Expenses | 453.5 | 544.6 | 488.2 | 387.0 | 512.1 | 473.9 | 501.9 | 378.2 | 596.2 | 653.0 |
| Operating Profit | 327.7 | 503.7 | 442.3 | 238.3 | 452.7 | 763.0 | 790.7 | 29.4 | 561.2 | 539.7 |
| OPM % | 41.95% | 48.05% | 47.53% | 38.11% | 46.92% | 61.69% | 61.17% | 7.21% | 48.49% | 45.25% |
| Other Income | 17.5 | 14.6 | 24.7 | 29.5 | 35.9 | 39.8 | 51.4 | 168.0 | 62.1 | 59.6 |
| Interest | 1.2 | 3.2 | 3.0 | 3.8 | 4.5 | 4.4 | 3.0 | 3.4 | 8.8 | 2.6 |
| Depreciation | 37.6 | 39.9 | 40.0 | 40.4 | 51.6 | 40.4 | 42.2 | 43.7 | 93.7 | 53.8 |
| Profit before tax | 306.4 | 475.2 | 424.0 | 223.6 | 432.5 | 758.0 | 796.9 | 150.3 | 520.8 | 542.9 |
| Tax % | -17.1% | -14.7% | -15% | -14.1% | -19.3% | -16.1% | -17% | -16.9% | -17.8% | 14.5% |
| Net Profit | 254.1 | 405.3 | 360.2 | 192.0 | 349.1 | 636.3 | 661.1 | 124.9 | 428.1 | 464.1 |
| EPS in Rs | 13.92 | 22.43 | 20.11 | 10.72 | 19.49 | 35.53 | 36.91 | 6.97 | 0 | 25.91 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 492.5 | 897.9 | 1,140.5 | 1,031.4 | 758.6 | 1,068.3 | 1,362.6 | 1,371.1 | 474.8 | 1,221.0 |
| Expenses | 386.6 | 558.8 | 612.5 | 573.4 | 490.5 | 571.0 | 557.8 | 566.8 | 436.0 | 672.9 |
| Operating Profit | 105.9 | 339.1 | 528.0 | 458.0 | 268.1 | 497.3 | 804.8 | 804.3 | 38.8 | 548.1 |
| OPM % | 21.5% | 37.77% | 46.3% | 44.41% | 35.34% | 46.55% | 59.06% | 58.66% | 8.17% | 44.89% |
| Other Income | 20.8 | 29.0 | 19.7 | 29.4 | 37.0 | 42.0 | 48.1 | 63.8 | 176.3 | 66.3 |
| Interest | 3.8 | 2.7 | 4.2 | 4.2 | 4.6 | 6.2 | 5.2 | 4.1 | 4.4 | 10.2 |
| Depreciation | 41.5 | 41.0 | 43.5 | 43.6 | 44.2 | 55.5 | 44.1 | 45.8 | 47.0 | 98.3 |
| Profit before tax | 81.4 | 324.4 | 500.0 | 439.6 | 256.3 | 477.6 | 803.6 | 818.2 | 163.7 | 505.9 |
| Tax % | -23.5% | -15% | -15.9% | -16.1% | -17% | -19.1% | 16.8% | -17.3% | -19.1% | -19.7% |
| Net Profit | 62.3 | 275.8 | 420.3 | 369.0 | 212.7 | 386.3 | 668.5 | 676.5 | 132.4 | 406.0 |
| EPS in Rs | 3.41 | 15.11 | 23.26 | 20.6 | 11.88 | 21.56 | 37.32 | 37.81 | 7.43 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 12% |
| 3 Years: | 29% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 15% |
| 3 Years: | 66% |
| TTM: | 46% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 8% |
| 3 Years: | 9% |
| 1 Year: | -14% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 14% |
| 3 Years: | 25% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 17% |
| 3 Years: | 49% |
| TTM: | 46% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 8% |
| 3 Years: | 9% |
| 1 Year: | -14% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|